Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 5 spellings of its name, each linked to the record.
As of Nov 22, 2026, FDA's public records list Rockwell Medical with 4 drug applications, 1 510(k) clearance, 1 device recall and 1 OPDP letter. The most recent is a drug application dated Mar 27, 2020: Triferic Avnu.
Drug approvals, 510(k) clearances, recalls and letters, 2018 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Mar 27, 2020 | Triferic AvnuNDA 212860 | Drug application |
| Nov 18, 2019 | Untitled letter: TrifericOffice of Prescription Drug Promotion | OPDP letter |
| Apr 7, 2018 | DriSate Product Code DR-145 The acid concentrate powders and liquids are indicated for use in acute and chronic hemodialysis and to be used…Class II · A subassembly component (dextrose bag) within this case product contained small amounts of sodium bicarbonate from a… | Device recall |
| Oct 20, 2016 | Rockwell Medical CitraPure Acid ConcetrateK160847 · KPO | 510(k) clearance |
| Apr 25, 2016 | TrifericNDA 208551 | Drug application |
| Jan 23, 2015 | TrifericNDA 206317 | Drug application |
| Sep 17, 2003 | CalcitriolANDA 76206 | Drug application |
What this company reported paying US doctors and teaching hospitals each year, $579K of it for research; see every company
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.